Treace Medical Concepts
(NASDAQ) TMCI
Treace Medical Concepts Financials at a Glance
Market Cap
$93.66M
Revenue (TTM)
$212.69M
Net Income (TTM)
$59.00M
EPS (TTM)
$-0.93
P/E Ratio
-1.55
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.45
Volume
15,832
Open
$1.35
Price
$1.45
Volume
15,832
Open
$1.35
Previous Close
$1.45
Daily Range
$1.35 - $1.46
52-Week Range
$1.17 - $8.13
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.45
Volume
15,832
Open
$1.35
Previous Close
$1.45
Daily Range
$1.35 - $1.46
52-Week Range
$1.17 - $8.13
TMCI News
TMCI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Treace Medical Concepts
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
450
CEO
John T. Treace
Website
www.treace.comHeadquarters
Ponte Vedra, FL 32081, US
TMCI Financials
Key Financial Metrics (TTM)
Gross Margin
80%
Operating Margin
-25%
Net Income Margin
-28%
Return on Equity
-59%
Return on Capital
-34%
Return on Assets
-31%
Earnings Yield
-64.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$93.66M
Shares Outstanding
64.59M
Volume
15.83K
Short Interest
0.00%
Avg. Volume
741.24K
Financials (TTM)
Gross Profit
$169.75M
Operating Income
$54.15M
EBITDA
$43.18M
Operating Cash Flow
$15.97M
Capital Expenditure
$13.52M
Free Cash Flow
$29.49M
Cash & ST Invst.
$48.37M
Total Debt
$13.98M
Treace Medical Concepts Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$62.52M
-9.0%
Gross Profit
$50.40M
-9.1%
Gross Margin
80.62%
N/A
Market Cap
$93.66M
N/A
Market Cap/Employee
$196.34K
N/A
Employees
477
N/A
Net Income
$9.39M
-1775.0%
EBITDA
$5.16M
-269.3%
Quarterly Fundamentals
Net Cash
$34.38M
+470.8%
Accounts Receivable
$42.16M
+3.3%
Inventory
$36.03M
-8.2%
Long Term Debt
$13.98M
-79.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
-30.96%
N/A
Return on Invested Capital
-33.86%
N/A
Free Cash Flow
$10.42M
-43.2%
Operating Cash Flow
$8.03M
-90.8%